Eli Lilly to offer early access to next-gen obesity drug to some patients - Reuters
Eli Lilly to offer early access to next-gen obesity drug to some patients Reuters
Coverage by Political Leaning
See how different sides of the spectrum reported this story
Key People
No people linked to this story
Locations
All Coverage
<a href="https://news.google.com/rss/articles/CBMiuAFBVV95cUxQSUF6THY1UW04aGlCR241STFzUE94MXlyMjZFSVNWaG9aYkRPVFVvdW5FRVZ3NHd3RXQzSjkybFhCWEhZZVpNTExxSDlwNDNRWW95SG0xcGVUVVozU09SMHR3RUR5b3Q2SFNYaTZvbzBWbV9fNTA4WjVOTGk1cUdhYkN2bl9rR19VcmpFV256VktIb243aHpZQ1RxNVR5ZldFNkpKUk9NNVFjb2Nmd1NxcFBDVzFnMURv?oc=5" target="_blank">Eli Lilly to offer early access to next-gen obesity drug to some patients</a> <font color="#6f6f6f">Reuters</font>
Similar Stories
Related coverage based on topic and tags
WHO endorses lifestyle changes over GLP-1 drugs in child obesity fight - Reuters
WHO endorses lifestyle changes over GLP-1 drugs in child obesity fight Reuters
October 7, 2026 at 07:39 AMUS FDA expands use of Novartis drug for chronic skin condition - Reuters
US FDA expands use of Novartis drug for chronic skin condition Reuters
October 7, 2026 at 04:51 PMPepsiCo running out of time to meet Elliott-inspired targets as GLP-1 threat intensifies - Reuters
PepsiCo running out of time to meet Elliott-inspired targets as GLP-1 threat intensifies Reuters
October 7, 2026 at 11:36 AMNew global guidelines warn against obesity drugs for children under 10
Care should focus on healthy eating and exercise, not medicines such as weight-loss injections, says the World Health Organization
October 7, 2026 at 08:07 AMViatris bets on non-opioid pain drugs with $1.65 billion Pacira deal - Reuters
Viatris bets on non-opioid pain drugs with $1.65 billion Pacira deal Reuters
October 8, 2026 at 02:39 PMNvidia-backed Iambic Therapeutics launches IPO as biotechs buck market gloom - Reuters
Nvidia-backed Iambic Therapeutics launches IPO as biotechs buck market gloom Reuters
October 8, 2026 at 06:18 PM